Evaluating Therapeutic Agents
The monitoring of animal behavior and physical presentation is key to understanding animal models of disease as well as assessing the effects of therapeutic agents. The Experimental Therapeutics Screening Facility is a unique collaborative research facility that supports both basic and translational research by testing preclinical therapeutics in vitro and in vivo.
Project managers will work closely with collaborators from academic institutions and research organizations to outline and oversee study design, resource allocation and budget. They will also help develop and manage project timelines while coordinating services provided by Sanford Research to facilitate the evaluation of therapeutic agents through high-content screening assays, behavioral assessments and a variety of histological, biochemical and molecular techniques.
Areas of Expertise
- Animal behavior, rodent surgical skills and physiological measures
- Custom in-situ hybridization (RNAscope) expertise for specific targeting, detection and analysis
- Histopathology and quantitative image analysis, including high-content imaging
- In vitro high-content screening and analysis for therapeutics
- Tailored gene expression design and analysis
The Experimental Therapeutics Screening Facility is focused on partnering with scientists to develop drug screening studies both in vitro and in vivo. Based on project needs, these services may include (but not limited to): high-content screening in various cell lines, short and long term rodent studies that include in-life behavior assessment, physiological measures, long-term survival studies and full necropsy, histopathological studies (including tissue processing and routine pathological stains/immunohistochemistry and imaging) and molecular biological services (rtPCR, RNAscope/in situ hybridization). The ETSF works in concert with a number of other Sanford cores including:
Meet Our Team
Benjamin Forred, MBA
Benjamin Forred has worked in the field of biomedical and clinical research for over ten years. He has spent much of that time in the research laboratory and has a background in cellular and molecular biology. For the past several years, Benjamin has served as a Director of Clinical Research at Sanford Research overseeing the research project management group, genetic & genomic studies, and Sanford’s rare disease registry, CoRDS. He also oversees the administration of the Experimental Therapeutics Screening Facility as the Director of Translational Research at Sanford Research.
Forred holds a B.S. in Biology, an MBA from the University of South Dakota, and a certificate in clinical trial conduct and management from the University of California at Berkeley.
Logan Langin, BA
Logan Langin earned a bachelor’s degree in biology from Augustana University in Sioux Falls, South Dakota. He oversees and manages all laboratory activities, orders, mouse colony maintenance and laboratory projects. Logan is involved in the analysis of behavioral, histopathological and molecular phenotypes in therapeutic studies in mouse models of Batten disease.
Attila Kovács, PhDDr. Attila Kovács holds a PhD in cell biology from Eötvös Loránd University in Budapest, Hungary, and completed postdoctoral training at the Karolinska Institute in Stockholm, Sweden, and the University of Rochester in Rochester, New York. He has extensive research experience in both pharmaceutical and academic environments with expertise in neuroscience and behavioral pharmacology.
Sanford Health News